Firefly Neuroscience, INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
NASDAQ
Firefly Neuroscience, Inc. reported a 957% revenue increase to $1.142 million in 2025, driven by the Evoke acquisition, but faces substantial doubt about its ability to continue as a going concern due to recurring losses and negative cash flows.
NASDAQ
10-K: Firefly Neuroscience's 10-K Filing Reveals AI-Driven Brain Health Strategy Amidst Liquidity Concerns
Firefly Neuroscience's latest 10-K filing highlights its focus on AI-driven neuroscientific solutions and commercial launch of the BNA Platform, while also acknowledging substantial doubt about its ability to continue as a going concern.
NASDAQ
WaveDancer Inc. reports a net loss for 2023, while undergoing a strategic shift including the sale of a subsidiary and a planned merger.